157 related articles for article (PubMed ID: 10914851)
1. Influenza virus vaccination of patients with systemic lupus erythematosus: effects on disease activity.
Abu-Shakra M; Zalmanson S; Neumann L; Flusser D; Sukenik S; Buskila D
J Rheumatol; 2000 Jul; 27(7):1681-5. PubMed ID: 10914851
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficiency of influenza vaccination in systemic lupus erythematosus patients.
Wallin L; Quintilio W; Locatelli F; Cassel A; Silva MB; Skare TL
Acta Reumatol Port; 2009; 34(3):498-502. PubMed ID: 19820674
[TBL] [Abstract][Full Text] [Related]
3. Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study.
Holvast A; van Assen S; de Haan A; Huckriede A; Benne CA; Westra J; Palache A; Wilschut J; Kallenberg CG; Bijl M
Rheumatology (Oxford); 2009 Oct; 48(10):1294-9. PubMed ID: 19692457
[TBL] [Abstract][Full Text] [Related]
4. The effect of menopause on disease activity in systemic lupus erythematosus.
Urowitz MB; Ibañez D; Jerome D; Gladman DD
J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease.
Holvast A; Huckriede A; Wilschut J; Horst G; De Vries JJ; Benne CA; Kallenberg CG; Bijl M
Ann Rheum Dis; 2006 Jul; 65(7):913-8. PubMed ID: 16322083
[TBL] [Abstract][Full Text] [Related]
6. Specific antibody response after influenza immunization in systemic lupus erythematosus.
Abu-Shakra M; Press J; Varsano N; Levy V; Mendelson E; Sukenik S; Buskila D
J Rheumatol; 2002 Dec; 29(12):2555-7. PubMed ID: 12465151
[TBL] [Abstract][Full Text] [Related]
7. Influenza virus vaccination of patients with SLE: effects on generation of autoantibodies.
Abu-Shakra M; Press J; Sukenik S; Buskila D
Clin Rheumatol; 2002 Sep; 21(5):369-72. PubMed ID: 12223983
[TBL] [Abstract][Full Text] [Related]
8. High disease activity: an independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus.
Campos LM; Silva CA; Aikawa NE; Jesus AA; Moraes JC; Miraglia J; Ishida MA; Bueno C; Pereira RM; Bonfa E
Arthritis Care Res (Hoboken); 2013 Jul; 65(7):1121-7. PubMed ID: 23818263
[TBL] [Abstract][Full Text] [Related]
9. Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity.
Del Porto F; Laganà B; Biselli R; Donatelli I; Campitelli L; Nisini R; Cardelli P; Rossi F; D'Amelio R
Vaccine; 2006 Apr; 24(16):3217-23. PubMed ID: 16466833
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus.
Ward MM; Marx AS; Barry NN
J Rheumatol; 2000 Mar; 27(3):664-70. PubMed ID: 10743805
[TBL] [Abstract][Full Text] [Related]
11. Menopause hormonal therapy in women with systemic lupus erythematosus.
Sánchez-Guerrero J; González-Pérez M; Durand-Carbajal M; Lara-Reyes P; Jiménez-Santana L; Romero-Díaz J; Cravioto MD
Arthritis Rheum; 2007 Sep; 56(9):3070-9. PubMed ID: 17763408
[TBL] [Abstract][Full Text] [Related]
12. Influenza vaccination of patients with systemic lupus erythematosus.
Mercado U; Acosta H; Avendaño L
Rev Invest Clin; 2004; 56(1):16-20. PubMed ID: 15144037
[TBL] [Abstract][Full Text] [Related]
13. Autoantibody response to adjuvant and nonadjuvant H1N1 vaccination in systemic lupus erythematosus.
Urowitz MB; Anton A; Ibanez D; Gladman DD
Arthritis Care Res (Hoboken); 2011 Nov; 63(11):1517-20. PubMed ID: 22034113
[TBL] [Abstract][Full Text] [Related]
14. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares.
Amoura Z; Combadiere C; Faure S; Parizot C; Miyara M; Raphaël D; Ghillani P; Debre P; Piette JC; Gorochov G
Arthritis Rheum; 2003 Dec; 48(12):3487-96. PubMed ID: 14673999
[TBL] [Abstract][Full Text] [Related]
15. Influenza vaccination of patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA).
Stojanovich L
Clin Dev Immunol; 2006; 13(2-4):373-5. PubMed ID: 17162380
[TBL] [Abstract][Full Text] [Related]
16. Extrarenal disease activity in systemic lupus erythematosus is not suppressed by chronic renal insufficiency or renal replacement therapy.
Bruce IN; Hallett DC; Gladman DD; Urowitz MB
J Rheumatol; 1999 Jul; 26(7):1490-4. PubMed ID: 10405935
[TBL] [Abstract][Full Text] [Related]
17. Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus.
Petri MA; Mease PJ; Merrill JT; Lahita RG; Iannini MJ; Yocum DE; Ginzler EM; Katz RS; Gluck OS; Genovese MC; Van Vollenhoven R; Kalunian KC; Manzi S; Greenwald MW; Buyon JP; Olsen NJ; Schiff MH; Kavanaugh AF; Caldwell JR; Ramsey-Goldman R; St Clair EW; Goldman AL; Egan RM; Polisson RP; Moder KG; Rothfield NF; Spencer RT; Hobbs K; Fessler BJ; Calabrese LH; Moreland LW; Cohen SB; Quarles BJ; Strand V; Gurwith M; Schwartz KE
Arthritis Rheum; 2004 Sep; 50(9):2858-68. PubMed ID: 15452837
[TBL] [Abstract][Full Text] [Related]
18. Raloxifene for postmenopausal women with systemic lupus erythematosus: a pilot randomized controlled study.
Mok CC; To CH; Mak A; Ma KM
Arthritis Rheum; 2005 Dec; 52(12):3997-4002. PubMed ID: 16320346
[TBL] [Abstract][Full Text] [Related]
19. Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus.
Holvast A; van Assen S; de Haan A; Huckriede A; Benne CA; Westra J; Palache A; Wilschut J; Kallenberg CG; Bijl M
Arthritis Rheum; 2009 Aug; 60(8):2438-47. PubMed ID: 19644961
[TBL] [Abstract][Full Text] [Related]
20. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
Feng X; Wu H; Grossman JM; Hanvivadhanakul P; FitzGerald JD; Park GS; Dong X; Chen W; Kim MH; Weng HH; Furst DE; Gorn A; McMahon M; Taylor M; Brahn E; Hahn BH; Tsao BP
Arthritis Rheum; 2006 Sep; 54(9):2951-62. PubMed ID: 16947629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
